Olema Oncology to Present at Oppenheimer 33rd Annual
SAN FRANCISCO, March 02, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq:
Globe Newswire3-03-2023, 04:07
Azerion confirms cancellation of 58,690,961 Treasury Shares 23-08-2023, 12:30